SMTL ID : 6bi0.2 (1 other biounit)

Trastuzumab Fab N158A, D185A, K190A (Light Chain) Triple Mutant.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.06 Å

Oligo State

hetero-1-1-mer

Ligands

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 3 residues within 4Å: Chain A: A.121, S.122, L.182 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.122 Water bridges: A:S.120, A:S.122, A:S.122 EDO.2: 6 residues within 4Å: Chain A: L.148, V.176, S.184, L.185, S.186 Chain B: T.178 6 PLIP interactions: 4 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:S.186, B:T.178 Water bridges: A:S.184, A:S.186, A:S.186, B:S.176 EDO.3: 6 residues within 4Å: Chain B: Q.37, Q.38, K.39, K.42, A.43, P.44 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:K.39

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pham, G.H. et al., Tuning a Protein-Labeling Reaction to Achieve Highly Site Selective Lysine Conjugation. Chembiochem (2018)

Release Date

2018-02-14

Peptides

Trastuzumab anti-HER2 Fab Heavy Chain: A
Trastuzumab anti-HER2 Fab Light Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
I

B
M

Trastuzumab anti-HER2 Fab Heavy Chain

Trastuzumab anti-HER2 Fab Light Chain

Related Entries With Identical Sequence